The Biological Activity of Ganoderma lucidum on Neurodegenerative Diseases: The Interplay between Different Active Compounds and the Pathological Hallmarks
Molecules · 2024
DOI: 10.3390/molecules29112516 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Wenhui Lian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Ginseng Academy, Changchun University of Traditional Chinese Medicine, Changchun 130117, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Reishi, Neuroprotective Agents. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: :The research was funded by Science and Technology Department of Jilin Provincial, Education Department of Jilin Province, Jilin Province Development and Reform Commission.
Abstract (Originalsprache)
Neurodegenerative diseases represent a cluster of conditions characterized by the progressive degeneration of the structure and function of the nervous system. Despite significant advancements in understanding these diseases, therapeutic options remain limited. The medicinal mushroom Ganoderma lucidum has been recognized for its comprehensive array of bioactive compounds with anti-inflammatory and antioxidative effects, which possess potential neuroprotective properties. This literature review collates and examines the existing research on the bioactivity of active compounds and extracts from Ganoderma lucidum in modulating the pathological hallmarks of neurodegenerative diseases. The structural information and preparation processes of specific components, such as individual ganoderic acids and unique fractions of polysaccharides, are presented in detail to facilitate structure–activity relationship research and scale up the investigation of in vivo pharmacology. The mechanisms of these components against neurodegenerative diseases are discussed on multiple levels and elaborately categorized in different patterns. It is clearly presented from the patterns that most polysaccharides of Ganoderma lucidum possess neurotrophic effects, while ganoderic acids preferentially target specific pathogenic proteins as well as regulating autophagy. Further clinical trials are necessary to assess the translational potential of these components in the development of novel multi-target drugs for neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jilin Ginseng Academy, Changchun University of Traditional Chinese Medicine, Changchun 130117, China.
- Guangdong Key Laboratory for Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Dongguan 523808, China.
Förderung
- :The research was funded by Science and Technology Department of Jilin Provincial
- Education Department of Jilin Province
- Jilin Province Development and Reform Commission
- Health Commission of Jilin Province
- Science and Technology Department of Jilin Province
Zitieren
APA
Lian, W., Yang, X., Duan, Q., Li, J., Zhao, Y., Yu, C., He, T., Sun, T., Zhao, Y., & Wang, W. (2024). The Biological Activity of Ganoderma lucidum on Neurodegenerative Diseases: The Interplay between Different Active Compounds and the Pathological Hallmarks. Molecules. https://doi.org/10.3390/molecules29112516
Vancouver
Lian W, Yang X, Duan Q, Li J, Zhao Y, Yu C, et al. The Biological Activity of Ganoderma lucidum on Neurodegenerative Diseases: The Interplay between Different Active Compounds and the Pathological Hallmarks. Molecules. 2024. doi:10.3390/molecules29112516
BibTeX
@article{Lian2024,
author = {Lian, Wenhui and Yang, Xu and Duan, Qidong and Li, Jie and Zhao, Yuting and Yu, Chunhui and He, Tianzhu and Sun, Tianxia and Zhao, Yu and Wang, Weinan},
title = {The Biological Activity of Ganoderma lucidum on Neurodegenerative Diseases: The Interplay between Different Active Compounds and the Pathological Hallmarks},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29112516}
}
EUVIMED